CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: All-Case Surveillance of Ofev in Patients With IPF in Japan
Summary
Completed all-case surveillance study of Ofev (nintedanib) in Japanese patients with idiopathic pulmonary fibrosis; results were posted in October 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED | Results posted: 2024-10-15